RAFT polymerization of bromotyramine-based 4-acryloyl-1,2,3-triazole: a functional monomer and polymer family through click chemistry

Sofyane Andjouh, Christine Bressy* and Yves Blache
Laboratoire Matériaux Polymères-Interfaces-Environnement Marin (MAPIEM), Université de Toulon, EA 4323, 83957 La Garde, France. E-mail: christine.bressy@univ-tln.fr; Fax: +33 4 94 14 24 48; Tel: +33 4 94 14 25 80

Received 23rd December 2015 , Accepted 20th January 2016

First published on 26th January 2016


Abstract

Four new functional acryloyl-triazole monomers derived from bromotyramine were successfully synthesized. These monomers were prepared in an efficient way from organic azides and propargyl acrylate via a copper catalyzed 1,3-dipolar cycloaddition. Polymers containing bromotyramine as a pendant group were obtained via reversible addition–fragmentation chain transfer (RAFT) polymerization. The influence of the chain transfer agent (CTA), solvent, temperature and the length of the linker between the triazole and bromotyramine groups on the polymerization kinetics was studied. It was found that triazoles containing acrylate monomers are characterized by fast polymerization and polymers with controlled molar masses (20[thin space (1/6-em)]000 g mol−1) and low dispersities (ĐM < 1.5) can be prepared. Glass transition temperatures of these acrylic polymers ranged from 48 °C to 20 °C by controlling the length of the linker between the bromotyramine side groups and the backbone.


1. Introduction

The prevention of biofilm development and the reduction of surface contamination are important issues in medical devices,1,2 food packaging,3,4 shipping,5 aquaculture,6 offshore petroleum industry7 etc. In the literature, antimicrobial and antibiofilm agents are numerous and used on a large-scale to prevent the adhesion of biofilms or to kill microorganisms. The incorporation of these biocides into coatings was the most efficient way to protect materials against microorganisms and inhibit the spread of microbial colonization.8–11 Any release of biocidal products from coatings into the surrounding environment leads to a decrease in efficacy with time. They were often found to be toxic against non-target species.12–23

An alternative approach is the design of polymers that can inhibit biofilm formation thanks to covalently linked biocidal side groups. This approach avoids any release of biocidal products and maintains a continuous activity.24 One method of achieving these polymers is to initially synthesize monomers containing biocidal moieties and then polymerize them subsequently or copolymerize them with other co-monomers.24–29 An alternative method is to chemically modify existing polymers.24,30,31 Then, biocidal polymers can be used as non-releasing coatings active by contact.32,33 The advantage of biocidal polymers is justified by the minimization of environmental impacts. Recently, the demand of eco-friendly antifouling materials has substantially increased and non-toxic strategies including the incorporation of natural antifouling compounds from marine organisms into coatings has been extensively investigated.10,34–38

Bromotyramine-based compounds e.g. Moloka'iamine (A),39,40 3,5-dibromo-4-methoxy-b-phenethylamine (B)41 and N-methyl-3-bromotyramine (C)42 have been reported into the literature to be efficient antifoulants against several marine organisms37,39,42,43 (Fig. 1). Synthetic analogues of this series of marine compounds were studied in our laboratory and were shown to display an anti-bacterial activity. Therefore, polymers containing bromotyramine side groups could be an alternative approach to develop surfaces which could inhibit any marine biofilm formation.


image file: c5ra27578d-f1.tif
Fig. 1 Bromotyramine derivatives.

The Cu-catalyzed Huisgen 1,3-cycloaddition is one of the most powerful post functionalization strategy. It has been combined with great success with controlled polymerization methods to synthesize a wide range of functional materials.31,44,45 There are a plethora of examples using the click chemistry in polymer science.45–47 The development of this reaction has also contributed to the design of a broad library of C-vinyl and N-vinyl-1,2,3-triazole based monomers and their resulting polymers.48–55 For example, a series of vinyl-1,2,3-triazole having various substituent groups has been reported to be successfully employed for the synthesis of functional polymers and block copolymers using conventional radical polymerization,55 reversible addition–fragmentation chain transfer (RAFT)48,51,52 and nitroxide-mediated polymerizations.49,50 Most of triazole containing polymers are prepared from conventional vinylic monomers. To our knowledge, no polymers have been prepared directly from acryloyl-1,2,3-triazole monomers via the RAFT process. The present study aims at preparing a series of 4-acryloyl-1,2,3-triazole (4-ATri) monomers and their resulting bromotyramine-containing homopolymers using the RAFT process. These polymers will combine the inherent properties of the 1,2,3-triazole linker group and the active bromotyramine group for further developing anti-adhesive surfaces for marine bacteria. The general structure of these novel monomers, as well as the synthetic pathway, are reported in Scheme 1. These monomers have been prepared in an efficient way from organic azides and propargyl acrylic via copper catalyzed 1,3-dipolar cycloaddition. The polymerization ability of these triazole acrylic monomers has been investigated and kinetics has been carried out to point out the controlled character of the polymerization process. Then, the thermal properties of the polymers were studied using differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA).


image file: c5ra27578d-s1.tif
Scheme 1 Synthetic pathways for triazole acrylate monomers and polymers.

2. Experimental section

Materials

Anhydrous acetonitrile (CH3–CN), N-bromosuccinimide (NBS), sodium carbonate (Na2CO3), sodium sulfate (Na2SO4), sodium azide (NaN3), N,N-dimethylformamide (DMF), dimethyl sulfoxide (DMSO), dimethyl sulfoxide-d6 (DMSO-d6), N,N-dimethylformamide-d7 (DMF-d7), chloroform-d (CDCl3), methanol, ethyl acetate (EtOAc), cyclohexane, diethyl ether (Et2O), propargyl acrylate, copper(II) sulfate pentahydrate (CuSO4·5H2O), sodium ascorbate, 1-(chloromethyl)-4-methoxybenzene, 1-(3-bromopropyl)-4-methoxybenzene and 4-methoxybenzyl chloride were purchased from Aldrich and used as received. 1-(2-Chloroethyl)-4-methoxybenzene was purchased from ACROS. Cyanomethyl dodecyl trithiocarbonate (CMDT) and 2-(dodecylthiocarbonothioylthio)-2-methylpropionic acid (DDMAT) were used as chain transfer agents (Aldrich). Azobis(isobutyronitrile) (AIBN, Aldrich) was recrystallized from methanol prior to be used.

Characterizations

1H- (400 MHz) and 13C- (100 MHz) NMR spectra were recorded on a Bruker Advance NMR spectrometer. Mass spectra were measured on an ion trap mass spectrometer fitted with an ESI interface (Esquire 6000, Bruker Daltonics). The number-average molar mass (Mn) and dispersity (ĐM) of polymers were determined by triple detection size exclusion chromatography (TD-SEC). Analyses were performed on a Viscotek apparatus, composed of a GPC Max (comprising a degasser, a pump and an autosampler) with a TDA-302 (refractive index detector, right and low angle light scattering detector at 670 nm and viscometer) and a UV detector (λ = 303 nm). The following columns were used: a Viscotek HHR-H precolumn and two Viscotek ViscoGel GMHHR-H columns. THF was used as the eluent with a flow rate of 1 mL min−1 at 30 °C. For each precipitated polymer, the refractive index increment (dn/dc) was determined using the OmniSec software, from a solution of known concentration (ca. 10 mg mL−1) filtered through a 0.2 μm PTFE filter.

The glass transition temperatures (Tg) of the homopolymers were measured with a Q10 differential scanning calorimeter (TA Instruments). The samples were cooled down to −10 °C or 0 °C and then scanned at a heating rate of 20 °C min−1 from −10 °C or 0 °C to 140 °C. The Tg values were determined as the midpoint between the onset and the end of a step transition on the second heating run using the TA Instruments Universal Analysis 2000 software.

Thermalgravimetric analysis (TGA) was conducted on a TA Instruments Q600 using a heating rate of 10 °C min−1 from 300 to 800 °C under constant nitrogen flow.

Typical experimental procedure for the bromination of methoxybenzene

General procedure for the synthesis of 2a–c. To a solution of appropriate aromatic halide (1a, 1b, 1c) (1 eq.) in anhydrous acetonitrile at 0 °C, was added portion wise N-bromosuccinimide (NBS) (1.5 eq.) under argon atmosphere. The mixture was stirred at room temperature for 4 h in which time TLC indicated complete conversion. Solvent was evaporated under vacuum and the residue was dissolved in Et2O. The organic layer was washed successively with sat. Na2CO3, sat. NaCl and H2O. The solvent was dried over Na2SO4 and concentrated under reduced pressure. The residue was used in the next step without further purification.
(1) 2-Bromo-4-(chloromethyl)-1-methoxybenzene (2a). 2a was prepared using 1-(chloromethyl)-4-methoxybenzene (1a) (4.7 g, 30 mmol) and NBS (8 g, 45 mmol) in acetonitrile (60 mL). 2a was obtained as a yellow oily substance (6.68 g, 94.5%).

1H NMR (400 MHz, CDCl3) δ 7.58 (d, 4J = 2.2 Hz, 1H, C–HAr.), 7.30 (dd, 3J = 8.4, 4J = 2.2 Hz, 1H, C–HAr), 6.87 (d, 3J = 8.4 Hz, 1H, C–HAr), 4.52 (s, 2H, [C with combining low line][H with combining low line]2–Cl), 3.90 (s, 3H, [C with combining low line][H with combining low line]3–O).

13C NMR (100 MHz, CDCl3) δ 155.5 ([C with combining low line]Ar–OCH3), 133.2 ([C with combining low line][H with combining low line]Ar), 130.6 ([C with combining low line]Ar), 128.7 ([C with combining low line][H with combining low line]Ar), 111.5 ([C with combining low line][H with combining low line]Ar), 111.2 ([C with combining low line][B with combining low line][r with combining low line]Ar), 55.9 ([C with combining low line][H with combining low line]3–O), 45.0 ([C with combining low line][H with combining low line]2–Cl).


(2) 2-Bromo-4-(2-chloroethyl)-1-methoxybenzene (2b). 2b was prepared using 1-(2-chloroethyl)-4-methoxybenzene (1b) (6.82 g, 40 mmol) and NBS (10.68 g, 60 mmol) in acetonitrile (80 mL). 2b was obtained as a yellow oily substance (9.9 g, 99%).

1H NMR (400 MHz, CDCl3) δ 7.41 (d, 4J = 2.2 Hz, 1H, C–HAr), 7.13 (dd, 3J = 8.4, 4J = 2.2 Hz, 1H, C–HAr), 6.85 (d, 3J = 8.4 Hz, 1H, C–HAr), 3.88 (s, 3H, [C with combining low line][H with combining low line]3–O), 3.67 (t, 3J = 7.3 Hz, 2H, CH2[C with combining low line][H with combining low line]2–Cl), 2.98 (t, 3J = 7.3 Hz, 2H, [C with combining low line][H with combining low line]2–CH2–Cl).

13C NMR (100 MHz, CDCl3) δ 154.1 ([C with combining low line]Ar–OCH3), 132.8 ([C with combining low line][H with combining low line]Ar), 131.0 ([C with combining low line]Ar), 128.4 ([C with combining low line][H with combining low line]Ar), 111.3 ([C with combining low line][H with combining low line]Ar), 110.8 (image file: c5ra27578d-t1.tif), 55.6 ([C with combining low line][H with combining low line]3–O), 44.5 (CH2[C with combining low line][H with combining low line]2–Cl), 37.1 ([C with combining low line][H with combining low line]2–CH2–Cl).


(3) 2-Bromo-4-(3-bromopropyl)-1-methoxybenzene (2c). 2c was prepared using 1-(chloromethyl)-4-methoxybenzene (1c) (3.44 g, 15 mmol) and NBS (4 g, 22.5 mmol) in acetonitrile (30 mL). 2c was obtained as a dark brown oily substance (4.58 g, 99%).

1H NMR (400 MHz, CDCl3) δ 7.39 (d, 4J = 2.2 Hz, 1H, C–HAr), 7.11 (dd, 3J = 8.4, 4J = 2.2 Hz, 1H, C–HAr), 6.84 (d, 3J = 8.4 Hz, 1H, C–HAr), 3.88 (s, 3H, [C with combining low line][H with combining low line]3–O), 3.38 (t, 3J = 6.5 Hz, 2H, [C with combining low line][H with combining low line]2–Br), 2.71 (t, J = 7.3 Hz, 2H, [C with combining low line][H with combining low line]2–CH2–CH2–Br), 2.13 (m, 2H, CH2[C with combining low line][H with combining low line]2–CH2–Br).

13C NMR (100 MHz, CDCl3) δ 154.0 ([C with combining low line]Ar–OCH3), 133.8 ([C with combining low line]Ar), 132.9 ([C with combining low line][H with combining low line]Ar), 128.3 ([C with combining low line][H with combining low line]Ar), 111.7 ([C with combining low line][H with combining low line]Ar), 111.2 (image file: c5ra27578d-t2.tif), 56.0 ([C with combining low line][H with combining low line]3–O), 33.8 (CH2–CH2[C with combining low line][H with combining low line]2–Br), 32.8 ([C with combining low line][H with combining low line]2–CH2–CH2–Br), 32.4 ([C with combining low line][H with combining low line]2–CH2–CH2–Br).

General procedure for the synthesis of azides 3a–d. A mixture of appropriate halide (1 equiv.) and sodium azide (NaN3) (2.6 equiv.) in N,N-dimethylformamide (DMF) was stirred for 5 h at 90 °C. The reaction temperature was allowed to warm to room temperature and the reaction mixture was diluted with Et2O. The organic phase was washed with brine and water, dried over Na2SO4, and concentrated under vacuum. The azide products were directly used for the next reaction without further purification.
(4) 4-(Azidomethyl)-2-bromo-1-methoxybenzene (3a). 3a was prepared using 2a (5.89 g, 25 mmol) and sodium azide (NaN3) (4.22 g, 65 mmol) in N,N-dimethylformamide (50 mL). 3a was obtained as dark brown oil (5.99 g, 99%).

1H NMR (400 MHz, CDCl3) δ 7.51 (d, 4J = 2.2 Hz, 1H, C–HAr), 7.23 (dd, 3J = 8.4, 4J = 2.2 Hz, 1H, C–HAr), 6.90 (d, 3J = 8.4 Hz, 1H, C–HAr), 4.26 (s, 2H, [C with combining low line][H with combining low line]2–N3), 3.90 (s, 3H, [C with combining low line][H with combining low line]3–O).

13C NMR (100 MHz, CDCl3) δ 155.2 ([C with combining low line]Ar–OCH3), 132.5 ([C with combining low line][H with combining low line]Ar), 128.4 ([C with combining low line]Ar), 128.0 ([C with combining low line][H with combining low line]Ar), 111.4 ([C with combining low line][H with combining low line]Ar), 111.1 (image file: c5ra27578d-t3.tif), 55.5 ([C with combining low line][H with combining low line]3–O), 52.9 ([C with combining low line][H with combining low line]2–N3).

IR (thin film) νN3 2092 cm−1.


(5) 4-(2-Azidoethyl)-2-bromo-1-methoxybenzene (3b). 3b was prepared using 2b (8.98 g, 36 mmol) and sodium azide (NaN3) (6.09 g, 93.6 mmol) in N,N-dimethylformamide (70 mL). 3b was obtained as dark brown oil (8.8 g, 95.5%).

1H NMR (400 MHz, CDCl3) δ 7.40 (d, 4J = 2.2 Hz, 1H, C–HAr), 7.12 (dd, 3J = 8.4, 4J = 2.2 Hz, 1H, C–HAr), 6.85 (d, 3J = 8.4 Hz, 1H, C–HAr), 3.88 (s, 3H, [C with combining low line][H with combining low line]3–O), 3.47 (t, 3J = 7.1 Hz, 2H, CH2[C with combining low line][H with combining low line]2–N3), 2.80 (t, 3J = 7.1 Hz, 2H, [C with combining low line][H with combining low line]2–CH2–N3).

13C NMR (100 MHz, CDCl3) δ 154.7 ([C with combining low line]Ar–OCH3), 133.4 ([C with combining low line][H with combining low line]Ar), 131.6 ([C with combining low line]Ar), 128.8 ([C with combining low line][H with combining low line]Ar), 111.9 ([C with combining low line][H with combining low line]Ar), 111.5 (image file: c5ra27578d-t4.tif), 56.2 ([C with combining low line][H with combining low line]3–O), 52.33 (CH2[C with combining low line][H with combining low line]2–N3), 34.04 ([C with combining low line][H with combining low line]2–CH2–N3).

IR (thin film) νN3 2090 cm−1.


(6) 1-(2-Azidoethyl)-4-methoxybenzene (3c). 3c was prepared using 1b (5.1 g, 30 mmol) and sodium azide (NaN3) (5.07 g, 78 mmol) in N,N-dimethylformamide (60 mL). 3c was obtained as yellow oil (5.06 g, 95%).

1H NMR (400 MHz, CDCl3) δ 7.16 (m, 2H, 2 C–HAr), 6.89 (m, 2H, 2 C–HAr), 3.81 (s, 3H, [C with combining low line][H with combining low line]3–O), 3.48 (t, J = 7.2 Hz, 2H, CH2[C with combining low line][H with combining low line]2–N3), 2.86 (t, J = 7.2 Hz, 2H, [C with combining low line][H with combining low line]2–CH2– N3).

13C NMR (100 MHz, CDCl3) δ 158.5 ([C with combining low line]Ar–OCH3), 130.0 ([C with combining low line]Ar), 129.7 (2 [C with combining low line]HA[r with combining low line]), 114.1 (2 [C with combining low line][H with combining low line]Ar), 55.2 ([C with combining low line][H with combining low line]3–O), 52.7 (CH2[C with combining low line][H with combining low line]2–N3), 34.5 ([C with combining low line][H with combining low line]2–CH2–N3).

IR (thin film) νN3 2090 cm−1.


(7) 4-(3-Azidopropyl)-2-bromo-1-methoxybenzene (3d). 3d was prepared using 2c (4 g, 13 mmol) and sodium azide (NaN3) (2.2 g, 33.8 mmol) in N,N-dimethylformamide (30 mL). 3d was obtained as dark brown oil (3.32 g, 94.5%).

1H NMR (400 MHz, CDCl3) δ 7.37 (d, 4J = 2.2 Hz, 1H, C–HAr), 7.08 (dd, 3J = 8.4, 4J = 2.2 Hz, 1H, C–HAr), 6.83 (d, 3J = 8.4 Hz, 1H, C–HAr), 3.87 (s, 3H, [C with combining low line][H with combining low line]3–O), 3.28 (t, J = 6.7 Hz, 2H, CH2–CH2[C with combining low line][H with combining low line]2–N3), 2.62 (t, J = 7.7 Hz, 2H, [C with combining low line][H with combining low line]2–CH2–CH2–N3), 1.87 (m, 2H, CH2[C with combining low line]H[2 with combining low line]–CH2–N3).

13C NMR (100 MHz, CDCl3) δ 154.0 ([C with combining low line]Ar–OCH3), 134.2 ([C with combining low line]Ar), 132.8 ([C with combining low line][H with combining low line]Ar), 128.2 ([C with combining low line][H with combining low line]Ar), 111.8 ([C with combining low line][H with combining low line]Ar), 111.3 ([C with combining low line][B with combining low line][r with combining low line]Ar), 55.9 ([C with combining low line][H with combining low line]3–O), 50.2 (CH2–CH2[C with combining low line][H with combining low line]2–N3), 31.2 ([C with combining low line][H with combining low line]2–CH2–CH2–N3), 30.2 (CH2[C with combining low line][H with combining low line]2–CH2–N3).

IR (thin film) νN3 2090 cm−1.

Typical method for preparation of monomers. An appropriate azide (1 equiv.) and propargyl acrylate (1.5 equiv.) were dissolved in a 1[thin space (1/6-em)]:[thin space (1/6-em)]2 mixture of water and ethanol. To the solution was added CuSO4·5H2O (0.04 equiv.) and sodium ascorbate (0.08 equiv.). The resultant mixture was stirred at room temperature for 12 h at which time TLC revealed complete conversion. The reaction solution was diluted with brine and extracted three times with EtOAc. The organic layers were washed with water, dried over Na2SO4 and evaporated under vacuum. Crude triazoles were purified by silica gel column chromatography using a mixture of EtOAc/cyclohexane (70/30) as mobile phase.
(8) (1-(3-Bromo-4-methoxybenzyl)-1H-1,2,3-triazol-4-yl)methyl acrylate (4-ATri 4a). 4-ATri 4a was obtained from azide 3a (4.84 g, 20 mmol) and methyl propiolate (3.3 g, 30 mmol) as white solid (6.78 g, 96%).

1H NMR (400 MHz, CDCl3) δ 7.56 (s, 1H, C–Htr.), 7.41 (d, 4J = 2.2 Hz, 1H, C–HAr), 7.14 (dd, 3J = 8.4, 4J = 2.2 Hz, 1H, C–HAr), 6.79 (d, 3J = 8.4 Hz, 1H, C–HAr), 6.30 (dd, 3J = 17.3, 2J = 1.4 Hz, 1H, CH[double bond, length as m-dash]CHHE), 6.00 (dd, 3J = 17.3, 3J = 10.4 Hz, 1H, CH[double bond, length as m-dash]CH2), 5.73 (dd, 3J = 10.4, 2J 1.4 Hz, 1H, CH[double bond, length as m-dash]CHHZ), 5.35 (s, 2H, [C with combining low line][H with combining low line]2–N), 5.17 (s, 2H [C with combining low line][H with combining low line]2–O–C[double bond, length as m-dash]O), 3.77 (s, 3H, [C with combining low line][H with combining low line]3–O).

13C NMR (100 MHz, CDCl3) δ 165.7 (C[double bond, length as m-dash]O), 156.0 ([C with combining low line]Ar–OMe), 143.0 ([C with combining low line]tr), 133.0 ([C with combining low line][H with combining low line]Ar), 131.4 (CH[double bond, length as m-dash][C with combining low line][H with combining low line]2), 128.5 ([C with combining low line][H with combining low line]Ar), 127.8 ([C with combining low line]Ar), 127.8 ([C with combining low line][H with combining low line][double bond, length as m-dash]CH2), 123.6 ([C with combining low line][H with combining low line]tr), 112.1 ([C with combining low line][H with combining low line]Ar), 111.9 ([C with combining low line][B with combining low line]rA[r with combining low line]), 57.5 ([C with combining low line][H with combining low line]3–O), 56.2 ([C with combining low line][H with combining low line]2–O–C[double bond, length as m-dash]O), 52.8 ([C with combining low line][H with combining low line]2–N).

Mp = 99–100 °C. (ESI, m/z) 352.05 ([M + H]+, 79Br) 354.02 ([M + H + 2]+, 81Br).


(9) (1-(3-Bromo-4-methoxyphenethyl)-1H-1,2,3-triazol-4-yl)methyl acrylate (4-ATri 4b). 4-ATri 4b was obtained from azide 3b (8.45 g, 33 mmol) and propargyl acrylate (5.45 g, 49.5 mmol) as white solid (11.7 g, 97%).

1H NMR (400 MHz, CDCl3) δ 7.41 (s, 1H, C–Htr), 7.14 (d, 4J = 2.1 Hz, 1H, C–HAr), 6.83 (dd, 3J = 8.4, 4J = 2.1 Hz, 1H, C–HAr), 6.66 (d, 3J = 8.4 Hz, 1H, C–HAr), 6.26 (dd, 3J = 17.3, 2J = 1.4 Hz, 1H, CH[double bond, length as m-dash]CHHE), 5.97 (dd, 3J = 17.3, 10.4 Hz, 1H, [C with combining low line][H with combining low line][double bond, length as m-dash]CH2), 5.70 (dd, 3J = 10.4, 2J = 1.4 Hz, 1H, CH[double bond, length as m-dash]CHHZ), 5.12 (s, 2H, [C with combining low line][H with combining low line]2–O–C[double bond, length as m-dash]O), 4.42 (t, J = 7.2 Hz, 2H, CH2[C with combining low line][H with combining low line]2–N), 3.69 (s, 3H, [C with combining low line][H with combining low line]3–O), 2.99 (t, J = 7.2 Hz, 2H, [C with combining low line][H with combining low line]2–CH2–N).

13C NMR (100 MHz, CDCl3) δ 165.5 (C[double bond, length as m-dash]O), 154.6 ([C with combining low line]Ar–OMe), 142.1 ([C with combining low line]tr), 133.0 ([C with combining low line][H with combining low line]Ar), 131.2 (CH[double bond, length as m-dash][C with combining low line][H with combining low line]2), 130.2 ([C with combining low line][H with combining low line]Ar), 128.5 ([C with combining low line]Ar), 127.7 ([C with combining low line][H with combining low line][double bond, length as m-dash]CH2), 124.0 ([C with combining low line][H with combining low line]tr), 111.8 ([C with combining low line][H with combining low line]Ar), 111.3 ([C with combining low line][B with combining low line][r with combining low line]Ar), 57.3 ([C with combining low line][H with combining low line]3–O), 55.9 ([C with combining low line][H with combining low line]2–O–C[double bond, length as m-dash]O), 51.2 (CH2[C with combining low line][H with combining low line]2–N), 35.0 ([C with combining low line][H with combining low line]2–CH2–N).

Mp = 69–70 °C. (ESI, m/z) 366.05 ([M + H]+, 79Br) 368.06 ([M + H + 2]+, 81Br).


(10) (1-(4-Methoxyphenethyl)-1H-1,2,3-triazol-4-yl)methyl acrylate (4-ATri 4c). 4-ATri 4c was obtained from azide 3c (4.78 g, 27 mmol) and propargyl acrylate (4.46 g, 40.5 mmol) as white solid (7.39 g, 95%).

1H NMR (400 MHz, CDCl3) δ 7.35 (s, 1H, C–Htr), 6.97–6.87 (m, 2H, 2C–HAr), 6.78–6.68 (m, 2H, 2C–HAr), 6.33 (dd, 3J = 17.3, 2J = 1.4 Hz, 1H, CH[double bond, length as m-dash]CHHE), 6.03 (dd, 3J = 17.3, 10.4 Hz, 1H, [C with combining low line][H with combining low line][double bond, length as m-dash]CH2), 5.76 (dd, 3J = 10.4, 2J = 1.4 Hz, 1H CH[double bond, length as m-dash]CHHZ), 5.18 (s, 2H, [C with combining low line][H with combining low line]2–O–C[double bond, length as m-dash]O), 4.46 (t, J = 7.3 Hz, 2H, CH2[C with combining low line][H with combining low line]2–N), 3.69 (s, 3H, [C with combining low line][H with combining low line]3–O), 3.06 (t, J = 7.3 Hz, 2H, [C with combining low line][H with combining low line]2–CH2–N).

13C NMR (100 MHz, CDCl3) δ 165.7 (C[double bond, length as m-dash]O), 158.5 ([C with combining low line]Ar–OMe), 142.2 ([C with combining low line]tr), 131.2 (CH[double bond, length as m-dash][C with combining low line][H with combining low line]2), 129.5 (2 [C with combining low line][H with combining low line]Ar), 128.7 ([C with combining low line]Ar), 127.8 ([C with combining low line][H with combining low line][double bond, length as m-dash]CH2), 124.1 ([C with combining low line][H with combining low line]tr), 114.0 (2 [C with combining low line][H with combining low line]Ar), 57.5 ([C with combining low line][H with combining low line]3–O), 55.0 ([C with combining low line]H[2 with combining low line]–O–C[double bond, length as m-dash]O), 51.7 (CH2[C with combining low line]H[2 with combining low line]–N), 35.7 ([C with combining low line][H with combining low line]2–CH2–N).

Mp = 42–43 °C. (ESI, m/z) 288.11 [M + H]+.


(11) (1-(3-(3-Bromo-4-methoxyphenyl)propyl)-1H-1,2,3-triazol-4-yl)methyl acrylate (4-ATri 4d). 4-ATri 4d was obtained from azide 3d (3.24 g, 12 mmol) and propargyl acrylate (1.98 g, 18 mmol) as yellow oil (4.38 g, 96%).

1H NMR (400 MHz, CDCl3) δ 7.58 (s, 1H, C–Htr), 7.28 (d, 4J = 2.2 Hz, 1H, C–HAr), 7.00 (dd, J = 8.4, 4J = 2.2 Hz, 1H, C–HAr), 6.77 (d, 3J = 8.4 Hz, 1H, C–HAr), 6.36 (dd, 3J = 17.3, 2J = 1.4 Hz, 1H, CH[double bond, length as m-dash]CHHE), 6.06 (dd, 3J = 17.3, 10.4 Hz, 1H, [C with combining low line][H with combining low line][double bond, length as m-dash]CH2), 5.79 (dd, 3J = 10.4, 2J = 1.4 Hz, 1H, CH[double bond, length as m-dash]CHHZ), 5.24 (s, 2H, [C with combining low line][H with combining low line]2–O–C[double bond, length as m-dash]O), 4.28 (t, J = 7.1 Hz, 2H, CH2–CH2[C with combining low line][H with combining low line]2–N), 3.79 (s, 3H, [C with combining low line][H with combining low line]3–O), 2.51 (t, J = 7.5 Hz, 2H, [C with combining low line][H with combining low line]2–CH2–CH2–N), 2.22–2.07 (m, 2H, CH2[C with combining low line][H with combining low line]2–CH2–N).

13C NMR (100 MHz, CDCl3) δ 165.9 (C[double bond, length as m-dash]O), 154.3 ([C with combining low line]Ar–OMe), 142.7 ([C with combining low line]tr), 133.6 ([C with combining low line][H with combining low line]Ar), 133.0 (CH[double bond, length as m-dash][C with combining low line][H with combining low line]2), 131.5 ([C with combining low line][H with combining low line]Ar), 128.4 ([C with combining low line]Ar), 127.9 ([C with combining low line][H with combining low line][double bond, length as m-dash]CH2), 123.8 ([C with combining low line][H with combining low line]tr), 112.0 ([C with combining low line][H with combining low line]Ar), 111.5 ([C with combining low line][B with combining low line][r with combining low line]Ar), 57.6 ([C with combining low line][H with combining low line]3–O), 56.2 ([C with combining low line][H with combining low line]2–O–C[double bond, length as m-dash]O), 49.3 (CH2–CH2[C with combining low line][H with combining low line]2–N), 31.5 ([C with combining low line][H with combining low line]2–CH2–CH2–N), 31.1 (CH2[C with combining low line][H with combining low line]2–CH2–N). (ESI, m/z) 380.06 ([M + H]+, 79Br) 382.06 ([M + H + 2]+, 79Br).

General procedure for RAFT polymerization. In situ 1H NMR RAFT polymerizations were carried out using CMDT or DDMAT as CTAs and AIBN as initiator at a molar ratio [CTA]/[AIBN] = 10. The concentration of CTA was adjusted to the targeted number-average molar mass (Mntarget), taking into account a full conversion of monomers and Mnth, calculated as follows (eqn (1)):
 
image file: c5ra27578d-t5.tif(1)
where [M]0 and [CTA]0 are the initial concentrations of monomer and CTA respectively, Mmonomer and MCTA are the molar mass of monomer and CTA respectively, and conv. is the monomer conversion.

All polymerizations were carried out in a high pressure/vacuum Wilmad NMR tube. A representative example is as follows: 4-ATri 4b (137 mg, 0.375 mmol), cyanomethyl dodecyl trithiocarbonate (CMDT) (2.2 mg, 0.007 mmol), AIBN (0.114 mg, 0.0007 mmol), and DMSO-d6 (0.25 mL) were placed in a dry high pressure/vacuum Wilmad NMR tube and then the solution was degassed by three freeze–evacuate–thaw cycles. The polymerization occurred into the NMR apparatus, heated at 60 °C during 15 h, and followed by 1H NMR analysis at regular times. After cooling down to room temperature, the crude sample was dissolved in a small amount of DMSO, purified by reprecipitation into a large excess of methanol, and the resulting product was dried under vacuum at room temperature (84 mg, yield 62%).

The conversion of 4-ATri 4b is determined from in situ 1H NMR analysis of the reaction mixture by comparing the integration (IH) area of peaks at 6.10–6.20 ppm (one vinylic proton of monomer) and the peak at 7.90–8.06 ppm corresponding to the triazole proton of both monomer and polymer. The conversion of 4-ATri 4b and MnNMR were determined with time as follows (eqn (2) and (3)):

 
image file: c5ra27578d-t6.tif(2)
with,
IH,polymer = IH,7.90–8.06 ppmIH,6.10–6.20 ppm

IH(monomer + polymer) = IH,7.90–8.06 ppm
 
image file: c5ra27578d-t7.tif(3)
where Mmonomer and MCTA are the molar mass of monomer and CTA respectively, and [CTA]chain end (t) is the concentration of CTA converted into macro-CTA with time.

The conversion of macro-CTA ([CTA]chain end (t)) is determined from in situ 1H NMR analysis of the reaction mixture by comparing the integration (IH) area of peaks at 4.4 ppm corresponding to two protons of unconsumed CTA (CH3–(CH2)11–S–(C[double bond, length as m-dash]S)–S–[C with combining low line][H with combining low line]2–CN) and the peak at 0.85 ppm corresponding to the three protons ([C with combining low line][H with combining low line]3–(CH2)11–S–(C[double bond, length as m-dash]S)–S–CH2–CN) of both unconsumed CTA and consumed CTA, as follows (eqn (4)):

 
image file: c5ra27578d-t8.tif(4)

The final molar mass (MnNMR) of the polymer is also determined after precipitation in methanol as follows (eqn (5)):

 
MNMRn = Xn × Mmonomer + MCTA (5)
where Xn is the number of repeating unit. Xn is determined from 1H NMR spectra of the purified polymer (Fig. 1–3 in ESI) by comparing the integration (IH) area of peaks at 3.80 ppm (methoxy protons (3H) of polymer) and the peak at 0.85 ppm corresponding to three protons of CTA inserted at the end of the polymer chains (eqn (6)).
 
image file: c5ra27578d-t9.tif(6)

3. Results and discussion

Synthesis of monomers

The synthesis of monomers 4a–d is outlined in Scheme 1.

The aryl azide intermediates were synthesized from commercially available benzyl halides (1a–c) as shown in Scheme 1. Briefly, each derivative (1a–c) was first brominated with N-bromosuccinimide (NBS) in anhydrous acetonitrile affording brominated derivatives 2a–c in excellent yields (>90%). Then, compounds 1b and 2a–c were treated with sodium azide in dimethylformamide leading to the corresponding azides 3a–d. Theses azides with different length of the methylene spacer between the aromatic ring and azide group were obtained with excellent yields (>90%) and did not require any purification.

The synthesis of the targeted acrylic monomers (4a–d) was then achieved by performing the copper-catalyzed 1,3-dipolar cycloaddition of the organic azides with propargyl acrylate. In general, this reaction usually proceeds to completion in 6–36 h at room temperature in water with a variety of organic co-solvents, such as tert-butanol, ethanol, DMF, DMSO, THF, or CH3CN. This reaction is used for a wide class of azides and alkynes.56 Ethanol was chosen rather than DMF to allow an easier workup and a better purity of products as reported in our previous work.57 In practice, propargyl acrylate was added to a solution of the appropriate azide (3a–d) with CuSO4/sodium ascorbate in water/ethanol mixture (50/50). A reaction time of 12 h was optimized at room temperature.

RAFT polymerization of monomers (4-ATri 4a–d)

The aim of this study was to demonstrate that the RAFT polymerization of these triazole containing monomers follows a controlled process. Herein, we first demonstrate the controlled character of the RAFT polymerization of 4-acryloyl-1-bromotyramine-1,2,3-triazole monomer (4-ATri 4b) which is the direct analogue of natural bromotyramines (Scheme 1). The RAFT polymerization was selected because it can be used with a wide range of monomers and reaction conditions, and in each case it provides polymers with controlled molar masses with narrow molar mass distributions.58 Furthermore, the atom transfer radical polymerization (ATRP) of a 4-acryloyl-1,2,3-triazole monomer (ferrocenylmethyl triazole methyl acrylate) has initially failed.59

First, kinetics was investigated by using conventional free radical polymerization (Table 1, entry Nr 1). The monomer 4-ATri 4b was successfully polymerized reaching 96% of conversion and leading to a polymer with a high molar mass (MnTD-SEC = 269[thin space (1/6-em)]600 g mol−1) and a high dispersity (ĐM = 3.8). 4-ATri 4b was further homopolymerized via the RAFT process to control the growth of polymer chains using two different CTAs.60–62 The reactivity of the RAFT agent has to be adjusted to the reactivity of the monomer to obtain good control over time while retaining an ideally unaltered rate of polymerization. The reactivity of a RAFT agent is governed by its R and Z groups. Scheme 2 shows the RAFT agents selected in our study.

Table 1 Experimental conditions for the RAFT polymerization of 4-ATri 4b using AIBN as initiator. Mn, and ĐM values obtained after 15 h of reaction
Entry CTA T (°C) Solvent Conv.a (%) Yieldb (%) Mnthc (g mol−1) MnTD-SECd (g mol−1) ĐMe dn/dcf
a Monomer conversion determined by 1H NMR (calculated from eqn (2)) at 15 h of reaction.b Yield determined gravimetrically.c Calculated from eqn (1).d Number-average molar mass obtained from TD-SEC.e ĐM = Mw/Mn obtained from TD-SEC.f Assessed by TD-SEC.g No polymer obtained.
1 70 DMSO 96 69 269[thin space (1/6-em)]600 3.8 0.069
2 CMDT 40 DMSO g g g g g g
3 CMDT 50 DMSO g g g g g g
4 CMDT 60 DMSO 97 62 19[thin space (1/6-em)]500 22[thin space (1/6-em)]100 1.3 0.111
5 CMDT 70 DMSO 99 53 19[thin space (1/6-em)]830 8600 2.9 0.112
6 CMDT 60 DMF 95 48 19[thin space (1/6-em)]000 23[thin space (1/6-em)]700 1.5 0.099
7 CMDT 70 DMF 97 42 19[thin space (1/6-em)]470 7170 2.7 0.118
8 DDMAT 60 DMSO 98 45 19[thin space (1/6-em)]490 18[thin space (1/6-em)]900 1.5 0.104



image file: c5ra27578d-s2.tif
Scheme 2 RAFT agents employed in the controlled radical polymerization of 4-ATri 4b.

The homopolymerizations were first carried out with CMDT in DMSO-d6 or DMF-d7 at a molar ratio [CTA]/[AIBN] of 10/1 at different temperatures. Whatever the conditions used, the targeted molar mass was 20[thin space (1/6-em)]000 g mol−1. The results are summarized in Table 1 (entries Nr 2 to 8). Polymerizations carried out at low temperatures (40 and 50 °C) failed because few amounts of radicals were generated at these lower temperatures. In addition, any impurities in monomer, RAFT agent or solvent could inhibit the polymerization (entries 2 and 3, respectively). At 60 °C, the disappearance of the vinyl protons from the acrylate group, around 5.6–6.4 ppm, and the appearance of broad peaks assigned to the main chain around 1.2–2.5 ppm (–CH2–) suggested the successful polymerization for 4-ATri 4b monomers (Fig. 2).


image file: c5ra27578d-f2.tif
Fig. 2 1HNMR spectra of (a) 4-ATri 4b in CDCl3, (b) its homopolymer poly(4-ATri 4b) after 15 h of reaction in DMSO-d6 at 60 °C, and (c) the purified polymer in CDCl3.

High monomer conversion values were obtained at 60 °C. The resulting poly(4-ATri 4b) exhibited a low dispersity value and the awaited Mn value (entry 4, Table 1). An increase of the reaction temperature to 70 °C led to faster kinetics with 86% of conversion after 1 h 30 min while the polymerization reached 83% of conversion after 5 h at 60 °C (ESI, Fig. 4). Nevertheless, polymers with lower Mn values (MnTD-SEC = 8600 g mol−1) than the targeted ones were obtained at 70 °C. In addition, the resulting poly(4-ATri 4b) showed a TD-SEC peak with a broad molar mass distribution (ĐM = 2.9). This result suggests that side reactions or termination steps could occur resulting in low molar mass and high dispersity values at 70 °C.

Similar kinetics was obtained in DMSO-d6 and in DMF-d7, whatever the reaction temperature (Fig. 4 in ESI). Polymers with lower dispersities were prepared at 60 °C in both solvents (Table 1, entries 4 and 6). The substitution of CMDT by DDMAT led to a slight increase of the dispersity value from 1.3 to 1.5 (Table 1, entries 6 and 8, Fig. 5 in ESI).

The linear semilogarithmic plots shown in Fig. 3 demonstrate a control of the growth of the polymer chains with time. The non-brominated monomer (4-ATri 4c) showed a higher reactivity than the brominated one (4-ATri 4b). The lower reactivity of 4-Tri-4b might result from a poorer solubility of this monomer relative to 4Tri-4c and from the steric effect of the bromine atom. Fig. 3 also shows that the length of the linker between the triazole function and the aromatic ring affects the polymerization rate of monomers. Increasing the methylene spacer from one carbon (4-ATri 4a) to two carbon atoms (4-ATri 4b) led to a decrease in polymerization rate. The increase of the length of the alkyl spacer should pull away the aromatic ring from the polymer backbone reducing any steric effect or electronic effect of the bromotyramine moiety on the polymerization rate. Surprisingly, the polymerisation rate of 4-ATri 4d (with three methylene groups) is higher than the one for 4-ATri 4b (with two methylene groups) which is slightly lower than the one found for 4-ATri 4a (with one methylene group). The origin of the slow polymerization kinetics of 4-ATri 4b comparing to the two other monomers was not investigated herein.


image file: c5ra27578d-f3.tif
Fig. 3 ln([M]0/[M]) vs. time. Homopolymerizations of triazole acrylates in DMSO-d6 at 60 °C. CMDT/AIBN molar ratio of 10/1. 4-ATri 4a (▲), 4-ATri 4b (■), 4-ATri 4c (o) and 4-ATri 4d (•).

In a representative plot of RAFT polymerization of 4-ATri 4b, MnNMR (t) increased linearly with monomer conversion, further confirming the controlled behavior of the polymerization process (Fig. 4). All other polymers showed similar linear relationships of MnNMR (t) with monomer conversion (ESI, Fig. 7–9). The final values of Mn were consistent with the expected ones with narrow molar mass distribution excepting for the one-carbon linker monomer (4-ATri 4a) where a higher MnTD-SEC was obtained (Table 2).


image file: c5ra27578d-f4.tif
Fig. 4 Evolution of MnNMR (t) vs. monomer conversion during the RAFT polymerization of a representative monomer 4-ATri 4b (■) in DMSO-d6 at 60 °C. Monomer/CMDT/AIBN molar ratio of 1.5/10/1. Mnth = 20[thin space (1/6-em)]000 g mol−1. The solid line is the linear fit to the data. The dashed line is corresponding to the theoretical line.
Table 2 Results for the RAFT polymerization of 4-ATri 4a–d at T = 60 °C, in DMSO-d6 after 15 h of reaction. Monomer/CMDT/AIBN molar ratio: 1.5/10/1
Monomer Conv.a (%) Yieldb (%) Mnthc (g mol−1) MnNMRd (g mol−1) MnTD-SECe (g mol−1) ĐMf dn/dcg
a Monomer conversion determined by 1H NMR (calculated from eqn (2)).b Yield determined gravimetrically.c Calculated from eqn (1).d Number-average molar mass obtained from 1H NMR using conversion of monomer (calculated from eqn (5)).e Number-average molar mass obtained from TD-SEC.f ĐM = Mw/Mn obtained from TD-SEC.g Obtained from TD-SEC.
4-ATri 4a 97 38 19[thin space (1/6-em)]480 34[thin space (1/6-em)]110 38[thin space (1/6-em)]500 1.19 0.124
4-ATri 4b 97 62 19[thin space (1/6-em)]500 22[thin space (1/6-em)]290 22[thin space (1/6-em)]100 1.28 0.111
4-ATri 4c 97 36 19[thin space (1/6-em)]510 19[thin space (1/6-em)]890 21[thin space (1/6-em)]700 1.37 0.111
4-ATri 4d 98 47 19[thin space (1/6-em)]600 19[thin space (1/6-em)]970 23[thin space (1/6-em)]500 1.28 0.109


Thermal properties

The thermal properties of the homopolymers were characterized by DSC. Thermal properties of homopolymers exhibited a strong relationship with length of the linker.

As shown in ESI(Fig. 10), 4-ATri-4d, which contains the longest linker, showed the lowest Tg around 20 °C, whereas 4-ATri 4b and 4-ATri 4a with shorter linkers exhibited Tg at 42 and 48 °C, respectively.

Clearly, the Tg value of homopolymers decreases with increasing the length of the linker between the bulky aromatic ring and the polymer backbone. The non-brominated monomer (4-ATri 4c) showed lower Tg (Tg = 34 °C) than the brominated one (4-ATri 4b). This result demonstrates the significant influence of the sterically hindered bromine atom on the mobility of the polymer main chain. This is in agreement with the previous behavior shown during the polymerization. The thermal degradation of the homopolymers was studied by TGA (ESI, Fig, 11 and 12). It was found that in inert atmosphere they all decompose in one major step, excepting the non-brominated one, with a maximum temperature around 320–330 °C leaving a residue (char) which is thermally quite stable, decomposing at a low rate at higher temperature. The first degradation step (100–200 °C) is assigned to the thermal decomposition of trithiocarbonate moieties, as previously reported.63

4. Conclusion

In this paper, new bromotyramine-based acryloyl-triazole monomers were synthesized with various lengths of methylene linkers between the triazole and the aromatic groups. Four monomers have been successfully prepared in high yields by taking advantage of the recently developed copper-catalyzed 1,3-dipolar cycloaddition reaction. The RAFT process enabled access to bromotyramine-containing homopolymers with narrow molar mass distributions and high conversions. The length of the linker and the bromination of the aromatic ring were shown to affect the kinetics of the RAFT polymerization. In addition, DSC analyses demonstrated that Tg values of homopolymers decreased with increasing the length of the linker. The bromine atom linked to the aromatic ring was shown to sterically affect the mobility of the polymer backbone leading to an increase of the Tg. No significant effect of the length of the linker on the thermal stability was demonstrated. Further investigations will be pursued to demonstrate that the RAFT polymerization is an effective way to prepare bromotyramine-based diblock copolymers. In addition, the marine bacterial anti-adhesion activity of bromotyramine-based polymers will be investigated. Triazolium-containing polymers could be also suitable as matrixes to promote the antibiofouling properties of coatings. Polytriazoliums prepared by a quaternization of the triazole groups will be a subsequent alternative to these materials.

Acknowledgements

This work was financially supported by the Université de Toulon (S. A. PhD grant).

References

  1. D. Lindsay and A. von Holy, J. Hosp. Infect., 2006, 64, 313 CrossRef CAS PubMed.
  2. A. Deshpande, G. W. G. Smith and A. J. Smith, J. Hosp. Infect., 2015, 90, 179 CrossRef CAS PubMed.
  3. S. Srey, I. K. Jahid and S.-D. Ha, Food Control, 2013, 31, 572 CrossRef.
  4. C. G. Kumar and S. K. Anand, Int. J. Food Microbiol., 1998, 42, 9 CrossRef CAS PubMed.
  5. D. M. Yebra, S. Kiil and K. Dam-Johansen, Prog. Org. Coat., 2004, 50, 75 CrossRef CAS.
  6. I. Fitridge, T. Dempster, J. Guenther and R. de Nys, Biofouling, 2012, 28, 649 CrossRef PubMed.
  7. T. Yan and W. X. Yan, Biofouling, 2003, 19, 133 CrossRef PubMed.
  8. A. A. Al-Juhni and B.-m. Z. Newby, Prog. Org. Coat., 2006, 56, 135 CrossRef CAS.
  9. E. Almeida, T. C. Diamantino and O. de Sousa, Prog. Org. Coat., 2007, 59, 2 CrossRef CAS.
  10. M. S. Acevedo, C. Puentes, K. Carreño, J. G. León, M. Stupak, M. García, M. Pérez and G. Blustein, Int. Biodeterior. Biodegrad., 2013, 83, 97 CrossRef CAS.
  11. M. Pérez, M. García, M. Sánchez, M. Stupak, M. Mazzuca, J. A. Palermo and G. Blustein, Int. Biodeterior. Biodegrad., 2014, 89, 37 CrossRef.
  12. C. L. Alzieu, J. Sanjuan, J. P. Deltreil and M. Borel, Mar. Pollut. Bull., 1986, 17, 494 CrossRef CAS.
  13. C. Alzieu, J. Sanjuan, P. Michel, M. Borel and J. P. Dreno, Mar. Pollut. Bull., 1989, 20, 22 CrossRef CAS.
  14. D. V. Ellis and L. Agan Pattisina, Mar. Pollut. Bull., 1990, 21, 248 CrossRef CAS.
  15. M. M. Saavedra Alvarez and D. V. Ellis, Mar. Pollut. Bull., 1990, 21, 244 CrossRef CAS.
  16. T. Nakanishi, J. Toxicol. Sci., 2008, 33, 269 CrossRef CAS PubMed.
  17. H. K. Okoro, O. S. Fatoki, F. A. Adekola, B. J. Ximba and R. G. Snyman, Asian J. Chem., 2011, 23, 473 CAS.
  18. Y. Kotake, Biol. Pharm. Bull., 2012, 35, 1876 CAS.
  19. R. A. Braithwaite and R. L. Fletcher, J. Exp. Mar. Biol. Ecol., 2005, 322, 111 CrossRef CAS.
  20. F. Cima, M. Bragadin and L. Ballarin, Aquat. Toxicol., 2008, 86, 299 CrossRef CAS PubMed.
  21. F. Gallucci, I. B. de Castro, F. C. Perina, D. M. de Souza Abessa and A. de Paula Teixeira, Ecol. Indic., 2015, 58, 21 CrossRef.
  22. F. Cima and L. Ballarin, Comp. Biochem. Physiol., C: Comp. Pharmacol., 2015, 169, 16 CrossRef CAS PubMed.
  23. E. Ytreberg, J. Karlsson and B. Eklund, Sci. Total Environ., 2010, 408, 2459 CrossRef CAS PubMed.
  24. E.-R. Kenawy, S. D. Worley and R. Broughton, Biomacromolecules, 2007, 8, 1359 CrossRef CAS PubMed.
  25. B. Dizman, M. O. Elasri and L. J. Mathias, Biomacromolecules, 2005, 6, 514 CrossRef CAS PubMed.
  26. H. Liu, B. Lepoittevin, C. Roddier, V. Guerineau, L. Bech, J.-M. Herry, M.-N. Bellon-Fontaine and P. Roger, Polymer, 2011, 52, 1908 CrossRef CAS.
  27. R. Adelmann, M. Mennicken, D. Popescu, E. Heine, H. Keul and M. Moeller, Eur. Polym. J., 2009, 45, 3093 CrossRef CAS.
  28. R. Jellali, I. Campistron, P. Pasetto, A. Laguerre, F. Gohier, C. Hellio, J.-F. Pilard and J.-L. Mouget, Prog. Org. Coat., 2013, 76, 1203 CrossRef CAS.
  29. A. Jain, L. S. Duvvuri, S. Farah, N. Beyth, A. J. Domb and W. Khan, Adv. Healthcare Mater., 2014, 3, 1969 CrossRef CAS PubMed.
  30. M. A. Gauthier, M. I. Gibson and H.-A. Klok, Angew. Chem., Int. Ed., 2009, 48, 48 CrossRef CAS PubMed.
  31. M. Semsarilar, V. Ladmiral and S. Perrier, Macromolecules, 2010, 43, 1438 CrossRef CAS.
  32. J. C. Tiller, C.-J. Liao, K. Lewis and A. M. Klibanov, Proc. Natl. Acad. Sci. U. S. A., 2001, 98, 5981 CrossRef CAS PubMed.
  33. S. B. Lee, R. R. Koepsel, S. W. Morley, K. Matyjaszewski, Y. Sun and A. J. Russell, Biomacromolecules, 2004, 5, 877 CrossRef CAS PubMed.
  34. J.-P. Maréchal and C. Hellio, Int. J. Mol. Sci., 2009, 10, 4623 CrossRef PubMed.
  35. R. de Nys, P. D. Steinberg, P. Willemsen, S. A. Dworjanyn, C. L. Gabelish and R. J. King, Biofouling, 1995, 8, 259 CrossRef CAS.
  36. C. Hellio, D. De La Broise, L. Dufossé, Y. Le Gal and N. Bourgougnon, Mar. Environ. Res., 2001, 52, 231 CrossRef CAS PubMed.
  37. R. C. Schoenfeld, S. Conova, D. Rittschof and B. Ganem, Bioorg. Med. Chem. Lett., 2002, 12, 823 CrossRef CAS PubMed.
  38. K. Hanssen, G. Cervin, R. Trepos, J. Petitbois, T. Haug, E. Hansen, J. Andersen, H. Pavia, C. Hellio and J. Svenson, Mar. Biotechnol., 2014, 16, 684 CrossRef CAS PubMed.
  39. S. Tsukamoto, H. Kato, H. Hirota and N. Fusetani, Tetrahedron, 1996, 52, 8181 CrossRef CAS.
  40. S. Tsukamoto, H. Kato, H. Hirota and N. Fusetani, J. Org. Chem., 1996, 61, 2936 CrossRef CAS PubMed.
  41. R. M. Van Wagoner, J. Jompa, A. Tahir and C. M. Ireland, J. Nat. Prod., 1999, 62, 794 CrossRef CAS PubMed.
  42. N. Pénez, G. Culioli, T. Pérez, J.-F. Briand, O. P. Thomas and Y. Blache, J. Nat. Prod., 2011, 74, 2304 CrossRef PubMed.
  43. J. A. Diers, H. K. Pennaka, J. Peng, J. J. Bowling, S. O. Duke and M. T. Hamann, J. Nat. Prod., 2004, 67, 2117 CrossRef CAS PubMed.
  44. V. Ladmiral, G. Mantovani, G. J. Clarkson, S. Cauet, J. L. Irwin and D. M. Haddleton, J. Am. Chem. Soc., 2006, 128, 4823 CrossRef CAS PubMed.
  45. W. H. Binder and R. Sachsenhofer, Macromol. Rapid Commun., 2007, 28, 15 CrossRef CAS.
  46. D. D. Díaz, S. Punna, P. Holzer, A. K. McPherson, K. B. Sharpless, V. V. Fokin and M. G. Finn, J. Polym. Sci., Part A: Polym. Chem., 2004, 42, 4392 CrossRef.
  47. B. Wang, M. Liu, Z. Chen, R. Liang, S. Ding, S. Chen and S. Jin, Int. J. Pharm., 2007, 331, 19 CrossRef CAS PubMed.
  48. R. J. Thibault, K. Takizawa, P. Lowenheilm, B. Helms, J. L. Mynar, J. M. J. Fréchet and C. J. Hawker, J. Am. Chem. Soc., 2006, 128, 12084 CrossRef CAS PubMed.
  49. H. Nulwala, K. Takizawa, A. Odukale, A. Khan, R. J. Thibault, B. R. Taft, B. H. Lipshutz and C. J. Hawker, Macromolecules, 2009, 42, 6068 CrossRef CAS.
  50. H. Nulwala, D. J. Burke, A. Khan, A. Serrano and C. J. Hawker, Macromolecules, 2010, 43, 5474 CrossRef CAS.
  51. M. Hetzer, G. Chen, C. Barner-Kowollik and M. H. Stenzel, Macromol. Biosci., 2010, 10, 119 CrossRef CAS PubMed.
  52. S. Beghdadi, I. Abdelhedi Miladi, H. Ben Romdhane, J. Bernard and E. Drockenmuller, Biomacromolecules, 2012, 13, 4138 CrossRef CAS PubMed.
  53. S. Beghdadi, I. A. Miladi, D. Addis, H. B. Romdhane, J. Bernard and E. Drockenmuller, Polym. Chem., 2012, 3, 1680 RSC.
  54. H. Mori, K. Ishikawa, Y. Abiko, Y. Maki, A. Onuma and M. Morishima, Macromol. Chem. Phys., 2012, 213, 1803 CrossRef CAS.
  55. B. J. Adzima, S. C. Taylor, H. He, D. R. Luebke, K. Matyjaszewski and H. B. Nulwala, J. Polym. Sci., Part A: Polym. Chem., 2014, 52, 417 CrossRef CAS.
  56. M. Meldal and C. W. Tornøe, Chem. Rev., 2008, 108, 2952 CrossRef CAS PubMed.
  57. D. Linares, O. Bottzeck, O. Pereira, A. Praud-Tabariès and Y. Blache, Bioorg. Med. Chem. Lett., 2011, 21, 6751 CrossRef CAS PubMed.
  58. C. Barner-Kowollik and S. Perrier, J. Polym. Sci., Part A: Polym. Chem., 2008, 46, 5715 CrossRef CAS.
  59. C. G. Hardy, L. Ren, T. C. Tamboue and C. Tang, J. Polym. Sci., Part A: Polym. Chem., 2011, 49, 1409 CrossRef CAS.
  60. J. Chiefari, Y. K. Chong, F. Ercole, J. Krstina, J. Jeffery, T. P. T. Le, R. T. A. Mayadunne, G. F. Meijs, C. L. Moad, G. Moad, E. Rizzardo and S. H. Thang, Macromolecules, 1998, 31, 5559 CrossRef CAS.
  61. C. Barner-Kowollik, in Handbook of RAFT Polymerization, Wiley-VCH Verlag GmbH & Co. KGaA, 2008, p. 1 Search PubMed.
  62. G. Moad, E. Rizzardo and S. H. Thang, Aust. J. Chem., 2009, 62, 1402 CrossRef CAS.
  63. B. Chong, G. Moad, E. Rizzardo, M. Skidmore and S. H. Thang, Aust. J. Chem., 2006, 59, 755 CrossRef CAS.

Footnote

Electronic supplementary information (ESI) available. See DOI: 10.1039/c5ra27578d

This journal is © The Royal Society of Chemistry 2016
Click here to see how this site uses Cookies. View our privacy policy here.